Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACTIVATED FACTOR-VII' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 139 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chuansumrit, A; Sri-Udomporn, N; Srimuninnimit, V; Juntarukha, R
      A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors

      HAEMOPHILIA
    2. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    3. Grunewald, M; Beneke, H; Guthner, C; Germowitz, A; Brommer, A; Griesshammer, M
      Acquired haemophilia: experiences with a standardized approach

      HAEMOPHILIA
    4. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    5. Castro, RR; Relinque, NB; Alvarez, AC; Montes, JMG; Gutierrez, JMH
      Use of recombinant factor VII in Hepatology

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    6. Poon, MC
      Use of recombinant factor VIIa in hereditary bleeding disorders

      CURRENT OPINION IN HEMATOLOGY
    7. Mutanen, M; Freese, R
      Fats, lipids and blood coagulation

      CURRENT OPINION IN LIPIDOLOGY
    8. Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ
      Plasma levels of factor XIIa and factor VIIa are increased but not relatedin primary hyperlipidaemia

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Berrettini, M; Mariani, G; Schiavoni, M; Rocino, A; Di Paolantonio, T; Longo, G; Morfini, M
      Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency

      HAEMATOLOGICA
    10. Mariani, G; Kroner, B
      Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success

      HAEMATOLOGICA
    11. Ewenstein, BM
      Continuous infusion of recombinant factor VIIa: Continue or not?

      THROMBOSIS AND HAEMOSTASIS
    12. Santagostino, E; Morfini, M; Rocino, A; Baudo, F; Scaraggi, FA; Gringeri, A
      Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

      THROMBOSIS AND HAEMOSTASIS
    13. Konigsberg, W; Kirchhofer, D; Riederer, MA; Nemerson, Y
      The TF : VIIa complex: Clinical significance, structure-function relationships and its role in signaling and metastasis

      THROMBOSIS AND HAEMOSTASIS
    14. Morrissey, JH
      Tissue factor: An enzyme cofactor and a true receptor

      THROMBOSIS AND HAEMOSTASIS
    15. Eriksson-Berg, M; Silveira, A; Orth-Gomer, K; Hamsten, A; Schenck-Gustafsson, K
      Coagulation factor VII in middle-aged women with and without coronary heart disease

      THROMBOSIS AND HAEMOSTASIS
    16. Blatt, J; Gold, SH; Wiley, JM; Monahan, PE; Cooper, HC; Harvey, D
      Off-label use of recombinant factor VIIa in patients following bone marrowtransplantation

      BONE MARROW TRANSPLANTATION
    17. Levesque, H; Borg, JY; Bossi, P; Goudemand, J; Guillet, B; Cabane, J
      Acquired haemophilia: diagnosis and therapeutic management.

      REVUE DE MEDECINE INTERNE
    18. Gill, JMR; Frayn, KN; Wootton, SA; Miller, GJ; Hardman, AE
      Effects of prior moderate exercise on exogenous and endogenous lipid metabolism and plasma factor VII activity

      CLINICAL SCIENCE
    19. Hansen, JB; Grimsgaard, S; Huseby, NE; Sandset, PM; Bonaa, KH
      Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men

      THROMBOSIS RESEARCH
    20. Hendriks, HGD; Meijer, K; de Wolf, JTM; Klompmaker, IJ; Porte, RJ; de Kam, PJ; Hagenaars, AJM; Melsen, T; Slooff, MJH; van der Meer, J
      Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation - A pilot study

      TRANSPLANTATION
    21. Hoffman, M; Monroe, DM
      The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis

      SEMINARS IN HEMATOLOGY
    22. Galan, AM; Tonda, R; Altisent, C; Maragall, S; Ordinas, A; Escolar, G
      Recombinant factor VIIa (NovoSeven (R)) restores deficient coagulation: Experience from an ex vivo model

      SEMINARS IN HEMATOLOGY
    23. Shapiro, A
      Inhibitor treatment: State of the art

      SEMINARS IN HEMATOLOGY
    24. Roberts, HR
      Recombinant factor VIIa (NovoSeven (R)) and the safety of treatment

      SEMINARS IN HEMATOLOGY
    25. Friederich, PW; Levi, M; Bauer, KA; Vlasuk, GP; Rote, WE; Breederveld, D; Keller, T; Spataro, M; Barzegar, S; Buller, HR
      Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects

      CIRCULATION
    26. Hunter, KA; Crosbie, LC; Horgan, GW; Miller, GJ; Dutta-Roy, AK
      Effect of diets rich in oleic acid, stearic acid and linoleic acid on postprandial haemostatic factors in young healthy men

      BRITISH JOURNAL OF NUTRITION
    27. Moscardo, F; Perez, F; de la Rubia, J; Balerdi, B; Lorenzo, JI; Senent, ML; Aznar, I; Carceller, S; Sanz, MA
      Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII

      BRITISH JOURNAL OF HAEMATOLOGY
    28. Chaney, JD; Nielsen, VG
      Considerations for the hemophiliac patient with inhibitors to factor VIII

      ANESTHESIA AND ANALGESIA
    29. Chaney, JD; Nielsen, VG
      Considerations for the hemophiliac patient with inhibitors to factor VIII

      ANESTHESIA AND ANALGESIA
    30. Sanders, TAB; Oakley, FR; Cooper, JA; Miller, GJ
      Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    31. Gale, AJ; Gordon, SG
      Update on tumor cell procoagulant factors

      ACTA HAEMATOLOGICA
    32. Martinowitz, U; Holcomb, JB; Pusateri, AE; Stein, M; Onaca, N; Freidman, M; Macaitis, JM; Castel, D; Hedner, U; Hess, JR
      Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    33. Lusher, JM
      Inhibitors in young boys with haemophilia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    34. Jimenez-Yuste, V; Villar, A; Morado, M; Canales, M; Hernandez, MC; Sanjurjo, MJ; Quintana, M; Hernandez-Navarro, F
      Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency

      HAEMOPHILIA
    35. Ton-That, TT; Doron, D; Pollard, BS; Bacher, J; Pollard, HB
      In vivo bypass of hemophilia A coagulation defect by Factor XIIa implant

      NATURE BIOTECHNOLOGY
    36. Ollivier, V; Chabbat, J; Herbert, JM; Hakim, J; de Prost, D
      Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    37. Bladbjerg, EM; Larsen, LF; Ostergaard, P; Jespersen, J
      In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. Possible implications for measurements in vivo after heparin therapy

      BLOOD COAGULATION & FIBRINOLYSIS
    38. Streif, W; Paes, B; Berry, L; Andrew, M; Andreasen, RB; Chan, AKC
      Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns

      BLOOD COAGULATION & FIBRINOLYSIS
    39. Arkin, S; Blei, F; Fetten, J; Foulke, R; Gilchrist, GS; Heisel, MA; Key, N; Kisker, CT; Kitchen, C; Shafer, FE; Shah, PC; Strickland, D
      Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors

      BLOOD COAGULATION & FIBRINOLYSIS
    40. Negrier, C; Lienhart, A
      Overall experience with NovoSeven (R)

      BLOOD COAGULATION & FIBRINOLYSIS
    41. Kenet, G; Lubetsky, A; Gitel, S; Luboshitz, J; Varon, D; Martinowitz, U
      Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

      BLOOD COAGULATION & FIBRINOLYSIS
    42. Brackmann, HH; Effenberger, E; Hess, L; Schwaab, R; Oldenburg, J
      NovoSeven (R) in immune tolerance therapy

      BLOOD COAGULATION & FIBRINOLYSIS
    43. Hedner, U
      NovoSeven (R) as a universal haemostatic agent

      BLOOD COAGULATION & FIBRINOLYSIS
    44. Berntorp, E; Stigendal, L; Lethagen, S; Olofsson, L; Hedner, U
      NovoSeven (R) in warfarin-treated patients

      BLOOD COAGULATION & FIBRINOLYSIS
    45. Al Douri, M; Shafi, T; Al Khudairi, D; Al Bokhari, E; Black, L; Akinwale, N; Musa, MO; Al Homaidhi, A; Al Fagih, M; Andreasen, RB
      Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven (R)) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery

      BLOOD COAGULATION & FIBRINOLYSIS
    46. Arnljots, B; Soderstrom, T; Ezban, M; Hedner, U
      Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis

      BLOOD COAGULATION & FIBRINOLYSIS
    47. Golino, P; Ragni, M; Cirillo, P; D'Andrea, D; Ravera, M; Calabro, P; Ezban, M; Tommasini, P; Chiariello, M
      Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction

      BLOOD COAGULATION & FIBRINOLYSIS
    48. de Maat, MPM; Pijl, H; Kluft, C; Princen, HMG
      Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals

      EUROPEAN JOURNAL OF CLINICAL NUTRITION
    49. Mrozikiewicz, PM; Cascorbi, I; Ziemer, S; Laule, M; Meisel, C; Stangl, V; Rutsch, W; Wernecke, K; Baumann, G; Roots, I; Stangl, K
      Reduced procedural risk for coronary catheter interventions in carriers ofthe coagulation factor VII-Gln(353) gene

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    50. Golino, P; Ragni, M; Cirillo, P; Scognamiglio, A; Ravera, A; Buono, C; Guarino, A; Piro, O; Lambiase, C; Botticella, F; Ezban, M; Condorelli, M; Chiariello, M
      Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    51. Aledort, LM
      Recombinant factor VIIa is a pan-hemostatic agent?

      THROMBOSIS AND HAEMOSTASIS
    52. Miller, GJ; Howarth, DJ; Attfield, JC; Cooke, CJ; Nanjee, MN; Olszewski, WL; Morrissey, JH; Miller, NE
      Haemostatic factors in human peripheral afferent lymph

      THROMBOSIS AND HAEMOSTASIS
    53. Monroe, DM; Hoffman, M; Allen, GA; Roberts, HR
      The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    54. Erhardtsen, E
      Pharmacokinetics of recombinant activated factor VII (rFVIIa)

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    55. Hunault, M; Bauer, KA
      Recombinant factor VIIa for the treatment of congenital factor VII deficiency

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    56. Negrier, C; Hay, CRM
      The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    57. Hansen, JB; Svensson, B; Sandset, PM; Thijssen, F
      Reduction of factor FVIIa activity during heparin therapy evidence for assay interactions with tissue factor pathway inhibitor and antithrombin

      THROMBOSIS RESEARCH
    58. Josic, D; Hoffer, L; Buchacher, A; Schwinn, H; Frenzel, W; Biesert, L; Klocking, HP; Hellstern, R; Rokicka-Milewska, R; Klukowska, A
      Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity

      THROMBOSIS RESEARCH
    59. Saigo, M; Abe, S; Ogawa, M; Biro, S; Minagoe, S; Maruyama, I; Toda, H; Kiyonaga, K; Atsuchi, Y; Tahara, M; Mawatari, K; Tei, C
      Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction

      THROMBOSIS RESEARCH
    60. Sanders, TAB; de Grassi, T; Miller, GJ; Morrissey, JH
      Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII)

      ATHEROSCLEROSIS
    61. Cooper, JA; Miller, GJ; Bauer, KA; Morrissey, JH; Meade, TW; Howarth, DJ; Barzegar, S; Mitchell, JP; Rosenberg, RD
      Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease

      CIRCULATION
    62. Green, D
      Complications associated with the treatment of haemophiliacs with inhibitors

      HAEMOPHILIA
    63. Teitel, JM
      Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerations

      HAEMOPHILIA
    64. Mariani, G; Conard, J; Bernardi, F; Bertina, R; Garcia, VV; Prydz, H; Samama, M; Sandset, PM; Puopolo, N; Ciarla, MV; Poso, R; Di Nucci, GD; Ceci, F; Marchetti, G
      Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    65. Tamaki, S; Iwai, N; Nakamura, Y; Tsujita, Y; Kinoshita, M
      Variation of the factor VII gene and ischemic heart disease in Japanese subjects

      CORONARY ARTERY DISEASE
    66. Tsujioka, H; Suehiro, A; Kakishita, E
      Activation of coagulation factor VII by tissue-type plasminogen activator

      AMERICAN JOURNAL OF HEMATOLOGY
    67. Harris, GM; Stendt, CL; Vollenhoven, BJ; Gan, TE; Tipping, PG
      Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives

      AMERICAN JOURNAL OF HEMATOLOGY
    68. Staudinger, T; Frass, M; Rintelen, C; Quehenberger, P; Wagner, O; Stoiser, B; Locker, GJ; Laczika, K; Knapp, S; Watzke, H
      Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients

      INTENSIVE CARE MEDICINE
    69. Scarabin, PY; Vissac, AM; Kirzin, JM; Bourgeat, P; Amiral, J; Agher, R; Guize, L
      Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives - A preliminary report

      THROMBOSIS AND HAEMOSTASIS
    70. Ruf, W; Mueller, BM
      Tissue factor signaling

      THROMBOSIS AND HAEMOSTASIS
    71. Hedner, U
      Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa

      THROMBOSIS AND HAEMOSTASIS
    72. Hellstern, P
      Production and composition of prothrombin complex concentrates: Correlation between composition and therapeutic efficiency

      THROMBOSIS RESEARCH
    73. Sanders, TAB; de Grassi, T; Miller, GJ; Humphries, SE
      Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    74. DANIELSEN R; ONUNDARSON PT; THORS H; VIDARSSON B; MORRISSEY JH
      ACTIVATED AND TOTAL COAGULATION-FACTOR-VII, AND FIBRINOGEN IN CORONARY-ARTERY DISEASE

      SCANDINAVIAN CARDIOVASCULAR JOURNAL
    75. SCHULMAN S
      SAFETY, EFFICACY AND LESSONS FROM CONTINUOUS-INFUSION WITH RFVIIA

      Haemophilia
    76. Lusher, JM; Roberts, HR; Davignon, G; Joist, JH; Smith, H; Shapiro, A; Laurian, Y; Kasper, CK; Mannucci, PM
      A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

      HAEMOPHILIA
    77. GOUDEMAND J
      RECOMBINANT FACTOR VIIA - A NEW TREATMENT OF HEMOPHILIA

      Transfusion clinique et biologique
    78. CARDIGAN RA; DONOHOE S; PURDY G; MACKIE IJ; MACHIN SJ
      THE ASSOCIATION OF FACTOR VIIA, FACTOR XIIA AND BETA(2)-GLYCOPROTEIN-1 WITH TRIGLYCERIDE-RICH LIPOPROTEINS IN NORMOLIPIDEMIC SUBJECTS

      Blood coagulation & fibrinolysis
    79. MENART C; COGNET V; PETIT PY; MASSIGNON D; NEGRIER C
      MANAGEMENT OF AN ANTI-FACTOR-VIII INHIBITOR OCCURRING DURING SURGICAL-PROCEDURE WITH CONTINUOUS-INFUSION OF NOVOSEVEN(R)

      Blood coagulation & fibrinolysis
    80. LUSHER J; INGERSLEV J; ROBERTS H; HEDNER U
      CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA

      Blood coagulation & fibrinolysis
    81. HEDNER U; INGERSLEV J
      CLINICAL USE OF RECOMBINANT FVIIA (RFVIIA)

      Transfusion science
    82. MARCKMANN P; BLADBJERG EM; JESPERSEN J
      DIET AND BLOOD-COAGULATION FACTOR-VII - A KEY PROTEIN IN ARTERIAL THROMBOSIS

      European journal of clinical nutrition
    83. PAPADAKI HA; XYLOURI I; VALATAS W; PETINARAKIS J; KONTOPOULOU I; ELIOPOULOS GD
      SEVERE ACQUIRED HEMOPHILIA-A SUCCESSFULLY TREATED WITH ACTIVATED RECOMBINANT HUMAN FACTOR-VII

      Annals of hematology
    84. IRISH AB; GREEN FR
      FACTOR-VII COAGULANT ACTIVITY (VIIC) AND HYPERCOAGULABILITY IN CHRONIC RENAL-DISEASE AND DIALYSIS - RELATIONSHIP WITH DYSLIPIDEMIA, INFLAMMATION, AND FACTOR-VII GENOTYPE

      Nephrology, dialysis, transplantation
    85. SHAPIRO AD; GILCHRIST GS; HOOTS WK; COOPER HA; GASTINEAU DA
      PROSPECTIVE, RANDOMIZED TRIAL OF 2 DOSES OF RFVIIA (NOVOSEVEN) IN HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING SURGERY

      Thrombosis and haemostasis
    86. KOHLER M; HELLSTERN P; LECHLER E; UBERFUHR P; MULLERBERGHAUS G
      THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH THE USE OF PROTHROMBIN COMPLEX AND FACTOR-IX CONCENTRATES

      Thrombosis and haemostasis
    87. PANKOW JS; FOLSOM AR; SHAHAR E; TSAI MY; JEFFERY RW; WING RR
      WEIGHT-LOSS INDUCED CHANGES IN PLASMA FACTOR-VII COAGULANT ACTIVITY AND RELATION TO THE FACTOR-VII ARG GLN(353) POLYMORPHISM IN MODERATELY OBESE ADULTS/

      Thrombosis and haemostasis
    88. WRIGHT D; POLLER L; THOMSON JM; SIDEBOTHAM A; HIRST CF; HIRSCH P
      A LONGITUDINAL-STUDY OF THE FACTOR-VII RISE DURING PREGNANCY

      Thrombosis and haemostasis
    89. Key, NS; Aledort, LM; Beardsley, D; Cooper, HA; Davignon, G; Ewenstein, BM; Gilchrist, GS; Gill, JC; Glader, B; Hoots, WK; Kisker, CT; Lusher, JM; Rosenfield, CG; Shapiro, AD; Smith, H; Taft, E
      Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors

      THROMBOSIS AND HAEMOSTASIS
    90. GOLINO P; RAGNI M; CIRILLO P; DANDREA D; SCOGNAMIGLIO A; RAVERA A; BUONO C; EZBAN M; CORCIONE N; VIGORITO F; CONDORELLI M; CHIARIELLO M
      ANTITHROMBOTIC EFFECTS OF RECOMBINANT HUMAN, ACTIVE SITE-BLOCKED FACTOR VIIA IN A RABBIT MODEL OF RECURRENT ARTERIAL THROMBOSIS

      Circulation research
    91. Ghaddar, HM; Folsom, AR; Aleksic, N; Hearne, LB; Chambless, LE; Morrissey, JH; Wu, KK
      Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis

      CIRCULATION
    92. DEMOERLOOSE P; AMIRAL J; VISSAC AM; REBER G
      LONGITUDINAL-STUDY ON ACTIVATED FACTOR-XII AND FACTOR-VII LEVELS DURING NORMAL-PREGNANCY

      British Journal of Haematology
    93. GREEN D; CHAMBERLAIN MA; RUTH KJ; FOLSOM AR; LIU K
      FACTOR-VII, CHOLESTEROL, AND TRIGLYCERIDES - THE CARDIA STUDY

      Arteriosclerosis, thrombosis, and vascular biology
    94. COBOS E; KEUNG YKK; AKHTER S; JONES J
      USE OF RECOMBINANT FACTOR VIIA FOR MAJOR ELECTIVE SURGERY IN A PATIENT WITH FACTOR-VII DEFICIENCY, RETROPERITONEAL FIBROSIS AND HYDRONEPHROSIS

      Clinical and applied thrombosis/hemostasis
    95. NISHIUMA S; KARIO K; NAKANISHI K; YAKUSHIJIN K; KAGEYAMA G; MATSUNAKA T; MATSUO T; KANAI N; IKEDA U; SHIMADA K; MATSUO M
      FACTOR-VII R353Q POLYMORPHISM AND LACUNAR STROKE IN JAPANESE HYPERTENSIVE PATIENTS AND NORMOTENSIVE CONTROLS

      Blood coagulation & fibrinolysis
    96. MILLER GJ
      DIETARY FATTY-ACIDS AND BLOOD-COAGULATION

      Prostaglandins, leukotrienes and essential fatty acids
    97. NAKASE T; WADA H; WAKITA Y; KANEKO T; DEGUCHI H; HIYOYAMA K; SHIMURA M; MORI Y; SHIKU H
      PLASMA-ACTIVATED FACTOR-VII LEVEL IN PATIENTS POSITIVE FOR LUPUS ANTICOAGULANT

      American journal of hematology
    98. MORRISSEY JH; NEUENSCHWANDER PF; HUANG QL; MCCALLUM CD; SU BX; JOHNSON AE
      FACTOR VIIA TISSUE FACTOR - FUNCTIONAL IMPORTANCE OF PROTEIN-MEMBRANEINTERACTIONS

      Thrombosis and haemostasis
    99. LUBON H; PALEYANDA RK
      VITAMIN-K-DEPENDENT PROTEIN-PRODUCTION IN TRANSGENIC ANIMALS

      Thrombosis and haemostasis
    100. MATSUO T; KOIDE M; KARIO K; SUZUKI S; MATSUO M
      EXTRINSIC COAGULATION-FACTORS AND TISSUE FACTOR PATHWAY INHIBITOR IN END-STAGE CHRONIC-RENAL-FAILURE

      Haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 04:33:18